Mai Capital Management Dario Health Corp. Transaction History

Mai Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.6 - $4.23 $31,860 - $51,834	-12,254 Reduced 11.41%	95,140 $312,000
Q2 2023 Aug 02, 2023	SELL	$3.2 - $4.33 $122,899 - $166,297	-38,406 Reduced 26.34%	107,394 $430,000
Q1 2023 May 10, 2023	SELL	$3.79 - $6.22 $87,101 - $142,948	-22,982 Reduced 13.62%	145,800 $600,000
Q4 2022 Feb 09, 2023	SELL	$3.53 - $5.49 $671,571 - $1.04 Million	-190,247 Reduced 52.99%	168,782 $722,000
Q3 2022 Nov 15, 2022	BUY	$3.74 - $7.09 $39,206 - $74,324	10,483 Added 3.01%	359,029 $1.66 Million
Q2 2022 Jul 19, 2022	BUY	$4.33 - $7.45 $1.51 Million - $2.6 Million	348,546 New	348,546 $2.14 Million

7.99M

104K

5.6K

Ticker DRIO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 23,295,000
Market Cap $17.2M
Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.